Leucid Bio

About:

Leucid is progressing novel cart therapies that produce a better and more durable response.

Website: http://www.leucid.com

Top Investors: British Business Bank, Sofinnova Partners, Epidarex Capital, Vulpes Investment Management Pte Ltd, 2invest

Description:

Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part of Leucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.